Table 4 |
||||||
|
Prognostic factors in 73 invasive ductal carcinomas compared with post-relapse survival |
||||||
|
Univariate |
Multivariate |
|||||
|
|
||||||
|
P |
RR |
95% CI |
P |
RR |
95% CI |
|
|
|
||||||
|
Age |
0.67 |
0.882 |
0.494–1.576 |
|||
|
Tumour size |
0.21 |
1.483 |
0.797–2.759 |
|||
|
Lymph node status |
0.40 |
0.746 |
0.376–1.479 |
|||
|
Histological grade |
0.15 |
0.500 |
0.197–1.271 |
|||
|
ER-α |
0.0009a |
0.342 |
0.181–0.645 |
0.79 |
1.174 |
0.354–3.886 |
|
PR |
0.0012a |
0.358 |
0.192–0.668 |
0.045a |
0.291 |
0.087–0.972 |
|
HER2 |
0.0024a |
3.637 |
1.582–8.362 |
0.0046a |
3.710 |
1.498–9.191 |
|
p53 |
0.0002a |
3.371 |
1.765–6.440 |
0.013a |
2.364 |
1.198–4.665 |
|
Ki67 |
0.16 |
1.539 |
0.849–2.790 |
|||
|
|
||||||
|
aP < 0.05 is considered significant. CI, confidence interval; ER, estrogen receptor; PR, progesterone receptor; RR, relative risk. |
||||||
|
Yamashita et al. Breast Cancer Research 2006 8:R48 doi:10.1186/bcr1536 |
||||||
